Mirum Pharmaceuticals Inc (MIRM)

Mirum Pharmaceuticals (MIRM) Stock Price & Analysis


MIRM Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$17.32 - $33.39
Previous Close$30.72
Average Volume (3M)593.87K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$329.95M
Total Debt (Recent Filing)$307.83M
Price to Earnings (P/E)-6.5
Nov 08, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.76
Shares Outstanding38,297,975
10 Day Avg. Volume1,032,204
30 Day Avg. Volume593,870
Standard Deviation0.38
Financial Highlights & Ratios
Price to Book (P/B)55.15
Price to Sales (P/S)36.20
Price to Cash Flow (P/CF)-131.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.00
Enterprise Value/Gross Profit0.00
Enterprise Value/Ebitda0.00
Price Target Upside86.20% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Mirum Pharmaceuticals Inc’s price range in the past 12 months?
Mirum Pharmaceuticals Inc lowest stock price was $17.32 and its highest was $33.39 in the past 12 months.
    What is Mirum Pharmaceuticals Inc’s market cap?
    Currently, no data Available
    When is Mirum Pharmaceuticals Inc’s upcoming earnings report date?
    Mirum Pharmaceuticals Inc’s upcoming earnings report date is Nov 08, 2023 which is in 46 days.
      How were Mirum Pharmaceuticals Inc’s earnings last quarter?
      Mirum Pharmaceuticals Inc released its earnings results on Aug 03, 2023. The company reported -$1.94 earnings per share for the quarter, missing the consensus estimate of -$0.755 by -$1.185.
        Is Mirum Pharmaceuticals Inc overvalued?
        According to Wall Street analysts Mirum Pharmaceuticals Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Mirum Pharmaceuticals Inc pay dividends?
          Mirum Pharmaceuticals Inc does not currently pay dividends.
          What is Mirum Pharmaceuticals Inc’s EPS estimate?
          Mirum Pharmaceuticals Inc’s EPS estimate is -$1.43.
            How many shares outstanding does Mirum Pharmaceuticals Inc have?
            Mirum Pharmaceuticals Inc has 38,297,974 shares outstanding.
              What happened to Mirum Pharmaceuticals Inc’s price movement after its last earnings report?
              Mirum Pharmaceuticals Inc reported an EPS of -$1.94 in its last earnings report, missing expectations of -$0.755. Following the earnings report the stock price went up 6.31%.
                Which hedge fund is a major shareholder of Mirum Pharmaceuticals Inc?
                Among the largest hedge funds holding Mirum Pharmaceuticals Inc’s share is Perceptive Advisors LLC. It holds Mirum Pharmaceuticals Inc’s shares valued at 16M.


                  Mirum Pharmaceuticals Stock Smart Score

                  The Mirum Pharmaceuticals stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
                  Learn more about TipRanks Smart Score

                  Company Description

                  Mirum Pharmaceuticals Inc

                  Mirum Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of a late-stage pipeline of novel therapies for debilitating liver diseases. Its product candidates include Maralixibat and Volixibat. The company was founded by Niall O'Donnel, Michael Grey and Christopher Peetz on May 7, 2018 and is headquartered in Foster City, CA.


                  Top 5 ETFs holding MIRM

                  Market Value
                  Smart Score
                  Vanguard Total Stock Market ETF
                  Xtrackers MSCI USA SWAP UCITS ETF Capitalisation 1C
                  Schwab U.S. Broad Market ETF
                  iShares Russell 3000 ETF
                  Vanguard Russell 3000 ETF
                  Up to five ETFs with an Outperform Smart Score that hold MIRM. The ETFs are listed according to market value of MIRM within the ETF

                  Forecast EPS vs Actual EPS

                  Similar Stocks
                  Price & Change
                  Bioxcel Therapeutics
                  Liquidia Technologies
                  Xeris Pharmaceuticals
                  Kala Pharmaceuticals

                  Popular Stocks

                  What's Included in PREMIUM?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis